Descriptive of serum trough activities of asparaginase (median; range)
| Day of induction treatment . | Recombinant asparaginase, N = 14 . | Asparaginase medac, N = 16 . |
|---|---|---|
| 15 | 137.80; 37.5-279.6 | 195.55; 37.5-345.8 |
| 18 | 164.75 84.9-282.2 | 204.20; 115.8-488.5 |
| 21 | 121.60; 37.5-275.8 | 163.90; 81.8-496.0 |
| 24 | 150.05; 102.7-369.4 | 207.60; 37.5-398.1 |
| 27 | 145.20; 76.7-291.3 | 189.30; 37.5-507.3 |
| 30 | 162.20; 37.5-324.8 | 193.60; 106.3-499.5 |
| 33 | 141.45; 37.5-394.5 | 179.25; 37.5-423.8 |
| 39 | 21.10; 1.3-177.0 | 16.30; 9.5-161.8 |
| Day of induction treatment . | Recombinant asparaginase, N = 14 . | Asparaginase medac, N = 16 . |
|---|---|---|
| 15 | 137.80; 37.5-279.6 | 195.55; 37.5-345.8 |
| 18 | 164.75 84.9-282.2 | 204.20; 115.8-488.5 |
| 21 | 121.60; 37.5-275.8 | 163.90; 81.8-496.0 |
| 24 | 150.05; 102.7-369.4 | 207.60; 37.5-398.1 |
| 27 | 145.20; 76.7-291.3 | 189.30; 37.5-507.3 |
| 30 | 162.20; 37.5-324.8 | 193.60; 106.3-499.5 |
| 33 | 141.45; 37.5-394.5 | 179.25; 37.5-423.8 |
| 39 | 21.10; 1.3-177.0 | 16.30; 9.5-161.8 |
Asparaginase infusions were administered on days 12, 15, 18, 21, 24, 27, 30, and 33.